Tuesday, October 7, 2025

Latest

PharmaCielo Conducts $4.0 Million Bought Deal Financing

PharmaCielo Ltd (TSXV: PCLO) is the latest firm to announce a bought deal financing. The firm announced this morning that a syndicate of underwriters lead by Cormark Securities and Stifel GMP had agreed to purchase roughly $4 million in common shares on a bought deal basis.

The terms of the financing will see 5,555,560 common shares of the company sold at a price of $0.72 per share. No warrant is involved in the financing. An over allotment option also exists for up to an additional 15.0% of common shares, which would increase the entire facility to $4.6 million.

Proceeds from the financing are to be used for working capital and general corporate purposes. The finanaince is anticipated to close on June 30, 2020.

PharmaCielo Ltd last traded at $0.85 on the TSX Venture.


Information for this briefing was found via Sedar and PharmaCielo Ltd. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Fortune Bay: The Potential Billion Dollar Project

Japan Gold Enters New Chapter as Barrick Alliance Concludes – John Proust

Barrick Mining’s “Company Defining [Gold] Discovery”

Recommended

Nord Precious Metals Produces High Grade Silver Concentrate From Tailings

ESGold Secures $9 Million In Non-Dilutive Funding From Ocean Partners

Related News

PharmaCielo Sees Marc Lustig Appointed As Lead Director, Conducts $10 Million Financing

It appears that PharmaCielo Ltd (TSXV: PCLO) has effectively locked in a new lead director....

Tuesday, November 3, 2020, 08:45:53 AM

Stifel Reinitiates Coverage On Eight Cannabis Operators

Earlier this week, Stifel released a new report on cannabis operations, focused predominantly on US-based...

Friday, July 24, 2020, 03:30:00 PM

PharmaCielo Struggles To Complete Financing, Extends Closing To March

It appears that PharmaCielo (TSXV: PCLO) is having a difficult time raising funds for its...

Friday, February 4, 2022, 08:22:08 AM

Drug Trade: The Three Basic Cannabis Health Company Archetypes

The popular belief that cannabis will work its way further into mainstream culture and further...

Saturday, December 21, 2019, 08:00:00 AM

Khiron Receives National Strategic Project Status From Colombian Government

This morning Khiron Life Sciences Corp (TSXV: KHRN) announced they received the status of National...

Tuesday, September 22, 2020, 09:43:55 AM